Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty-Four of the GO-VIBRANT Study
To evaluate the safety and efficacy of intravenous (IV) golimumab treatment in psoriatic arthritis (PsA)
Článek, 2017